Zynerba is dedicated to improving the lives of people with rare and near rare neuropsychiatric disorders where there is a high unmet medical need by pioneering the development and commercialization of next-generation pharmaceutically-produced cannabinoid therapeutics formulated for transdermal delivery.

Pharmaceutical

Zynerba Pharma

Zynerba Pharma's headquarters in Devon, PA, United States

Brian Rosenberger

Terri B. Sebree

Paul M. Kirsch

Melanie van Buuren

Samantha Labarbera

Terry Hurst

Ray Mannion

Carol O’Neill

Stan Banks

Carolyn Kreusser

Shelly Weeks-Townsend

Pamela Stephenson

Elizabeth M. Berry-Kravis

Craig A. Erikson

Nicole Tartaglia

Warren D. Cooper

John P. Butler

William J. Federici

Daniel L. Kisner

Kenneth I. Moch

Randi J. Hagerman

Steven J. Siegel

Kathleen Angkustsiri

Carrie Buchanan

Tony Simon

Helen Heussler

The Directors and VPs at Zynerba Pharma are responsible for guiding the company's strategic direction and ensuring the successful development and commercialization of transdermal cannabinoid therapeutics. This team oversees key areas including medical affairs, manufacturing, business development, clinical development, regulatory affairs, quality assurance, and product development, collectively driving efforts to meet high unmet medical needs in neuropsychiatric disorders.

Directors and VPs

The Leadership Team at Zynerba Pharma plays a crucial role in guiding the company's strategic direction and ensuring alignment with its mission to develop cannabinoid therapeutics for neuropsychiatric disorders. This team comprises executives overseeing key functions such as commercial development, clinical trials, manufacturing, and legal compliance, all collaborating to drive innovation, navigate regulatory landscapes, and enhance operational efficiency to fulfill the unmet medical needs of patients.

Leadership Team

The Scientific Advisory Team at Zynerba Pharma provides expert guidance on the research and development of novel cannabinoid therapeutics, ensuring they meet the highest scientific and clinical standards. Comprised of leading scientific advisors and coordinated by the Research Study Coordinator, this team evaluates clinical data, advises on study designs, regulatory strategies, and helps align the company's initiatives with the latest scientific advancements to address unmet medical needs in neuropsychiatric disorders.

Scientific Advisory Team

Zynerba Pharma

Org chart

Board & advisors

Teams

Directors and VPs

Leadership Team

Scientific Advisory Team

Offices

Zynerba Pharma

Org chart

Board & advisors

Teams

Directors and VPs

Leadership Team

Scientific Advisory Team

Offices

Related companies